Recent studies have reported that ANGPTL4 is upregulated in models of conditions such as IgA nephropathy [30], cisplatin-induced acute kidney injury [31], nephrotic syndrome [32–34], and diabetic nephropathy [35–37], promoting renal injury. Here, ANGPTL4 is linked to IgA glomerulonephritis.